|52 Week Rng||-|
|P/E Ratio (TTM)||-|
|P/E Ratio (Fwd)||-|
|Div & Yield||-|
Following our industry and ESG focused passive strategy: Investing in the top 8 medical companies with an ESG score at least 60. Weights in portfolio are based on calculated index which is based on ESG scores in Dow Jones database.
Seasonality & Momentum strategy | Equal weighting | Aiming to achieve the target 1.9 leverage ratio | HOLX is a seasonality stock with high historical profits in November and it has had some good momentum recently which we believe to continue.
According to our strategy we re-build our portfolio for each month. Therefore we close the position in the company initiated in January.